Anzeige
Mehr »
Montag, 19.01.2026 - Börsentäglich über 12.000 News
Goldaktie des Tages: Weiteres Upside-Potential enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
16.01.26 | 22:00
0,625 US-Dollar
-5,89 % -0,039
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiMANGOCEUTICALS, INC. - S-1, General form for registration of securities1
19.12.25Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements2
19.12.25Mangoceuticals announces $100 million Solana-focused strategy2
19.12.25Mangoceuticals setzt auf Solana: Neue Treasury-Strategie über 100 Millionen US-Dollar1
MANGOCEUTICALS Aktie jetzt für 0€ handeln
19.12.25Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy7
19.12.25MANGOCEUTICALS, INC. - 8-K, Current Report1
18.12.25Mangoceuticals prices $2.5M registered direct offering with warrants1
18.12.25Mangoceuticals secures $2.5 million through registered direct offering4
18.12.25Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules1
10.12.25MANGOCEUTICALS, INC. - 8-K, Current Report-
14.11.25MANGOCEUTICALS, INC. - 10-Q, Quarterly Report-
14.11.25Eli Lilly and Novo Nordisk disown Mangoceuticals' GLP-1RA partnership claim39
14.11.25Mangoceuticals plunges after denying Lilly, Novo partnerships22
14.11.25Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs2.185Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier...
► Artikel lesen
13.11.25Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals39
13.11.25Mangoceuticals: Aktie stürzt nach Dementi von Novo Nordisk und Eli Lilly ab53
13.11.25Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs50
13.11.25Mangoceuticals launches direct GLP-1 medication access programs21
13.11.25MANGOCEUTICALS, INC. - 8-K, Current Report-
12.09.25MANGOCEUTICALS, INC. - 8-K, Current Report1
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1